A carregar...
New treatment options for metastatic renal cell carcinoma
During the last decade, the treatment of advanced or metastatic renal cell carcinoma (RCC) was revolutionised with the advent of antiangiogenic drugs and tyrosine-kinase inhibitors. Several agents targeting the vascular endothelial growth factor (VEGF) pathway (sunitinib, bevacizumab, pazopanib, axi...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
ESMO Open
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519813/ https://ncbi.nlm.nih.gov/pubmed/28761748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000185 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|